Literature DB >> 18927213

Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization.

Alexander Misharin1, Martin Hewison, Chun-Rong Chen, Venu Lagishetty, Holly A Aliesky, Yumiko Mizutori, Basil Rapoport, Sandra M McLachlan.   

Abstract

TSH receptor (TSHR) antibodies and hyperthyroidism are induced by immunizing mice with adenovirus encoding the TSHR or its A-subunit. Depleting regulatory T cells (Treg) exacerbates thyrotoxicosis in susceptible BALB/c mice and induces hyperthyroidism in normally resistant C57BL/6 mice. Vitamin D plays an important role in immunity; high dietary vitamin D intake suppresses (and low intake enhances) adaptive immune responses. Vitamin D-induced immunosuppression may enhance Treg. Therefore, we hypothesized that decreased vitamin D intake would mimic Treg depletion and enhance hyperthyroidism induced by A-subunit adenovirus immunization. BALB/c mice had a reduced ability vs. C57BL/6 mice to generate the active metabolite of vitamin D (1,25-dihydroxyvitamin D3). Vitamin D deficiency induced subtle immune changes in BALB/c (not C57BL/6) mice. Compared with mice fed regular chow, vitamin D-deprived BALB/c mice had fewer splenic B cells and decreased interferon-gamma responses to mitogen and lacked memory T-cell responses to A-subunit protein. However, vitamin D deficiency did not alter TSHR antibody responses measured by ELISA, TSH binding inhibition, or cAMP generation from TSHR-expressing cells. Unexpectedly, compared with vitamin D-sufficient mice, vitamin D-deficient BALB/c mice had lower preimmunization T(4) levels and developed persistent hyperthyroidism. This difference was unrelated to the immunological changes between vitamin D-deficient or -sufficient animals. Previously, we found that different chromosomes or loci confer susceptibility to TSHR antibody induction vs. thyroid function. Our present studies provide evidence that an environmental factor, vitamin D, has only minor effects on induced immunity to the TSHR but directly affects thyroid function in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927213      PMCID: PMC2646531          DOI: 10.1210/en.2008-1191

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  46 in total

1.  Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera.

Authors:  G D Chazenbalk; J C Jaume; S M McLachlan; B Rapoport
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  Targeted expression of the human thyrotropin receptor A-subunit to the mouse thyroid: insight into overcoming the lack of response to A-subunit adenovirus immunization.

Authors:  Pavel N Pichurin; Chun-Rong Chen; Gregorio D Chazenbalk; Holly Aliesky; Nancy Pham; Basil Rapoport; Sandra M McLachlan
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

3.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.

Authors:  N Mittereder; K L March; B C Trapnell
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.

Authors:  Yuji Nagayama; Masako Kita-Furuyama; Takao Ando; Kazuhiko Nakao; Hiroyuki Mizuguchi; Takao Hayakawa; Katsumi Eguchi; Masami Niwa
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

5.  1Alpha,25-dihydroxyvitamin D3 up-regulates Bcl-2 expression and protects normal human thyrocytes from programmed cell death.

Authors:  S H Wang; R J Koenig; T J Giordano; A Myc; N W Thompson; J R Baker
Journal:  Endocrinology       Date:  1999-04       Impact factor: 4.736

6.  1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).

Authors:  L Overbergh; B Decallonne; M Waer; O Rutgeerts; D Valckx; K M Casteels; J Laureys; R Bouillon; C Mathieu
Journal:  Diabetes       Date:  2000-08       Impact factor: 9.461

7.  Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease.

Authors:  Y Ban; Y Ban; M Taniyama; T Katagiri
Journal:  Thyroid       Date:  2000-05       Impact factor: 6.568

8.  1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis.

Authors:  M T Cantorna; C E Hayes; H F DeLuca
Journal:  J Nutr       Date:  1998-01       Impact factor: 4.798

9.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.

Authors:  M T Cantorna; C E Hayes; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

10.  A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies.

Authors:  G D Chazenbalk; Y Wang; J Guo; J S Hutchison; D Segal; J C Jaume; S M McLachlan; B Rapoport
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

View more
  45 in total

1.  Vitamin D and autoimmune thyroid diseases.

Authors:  Shaye Kivity; Nancy Agmon-Levin; Michael Zisappl; Yinon Shapira; Endre V Nagy; Katalin Dankó; Zoltan Szekanecz; Pnina Langevitz; Yehuda Shoenfeld
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Variable suppression of serum thyroxine in female mice of different inbred strains by triiodothyronine administered in drinking water.

Authors:  Sepehr Hamidi; Holly Aliesky; Chun-Rong Chen; Basil Rapoport; Sandra M McLachlan
Journal:  Thyroid       Date:  2010-10       Impact factor: 6.568

3.  A local effect of CYP24 inhibition on lung tumor xenograft exposure to 1,25-dihydroxyvitamin D(3) is revealed using a novel LC-MS/MS assay.

Authors:  Jan H Beumer; Robert A Parise; Beatriz Kanterewicz; Martin Petkovich; David Z D'Argenio; Pamela A Hershberger
Journal:  Steroids       Date:  2012-01-20       Impact factor: 2.668

4.  Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Betina Heinsbæk Thuesen; Allan Linneberg
Journal:  Endocrine       Date:  2015-02-11       Impact factor: 3.633

5.  Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for Aire in tolerance for thyroid autoantigens.

Authors:  Alexander V Misharin; Yuji Nagayama; Holly A Aliesky; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2009-03-05       Impact factor: 4.736

6.  Vitamin D regulation of OX40 ligand in immune responses to Aspergillus fumigatus.

Authors:  Nikki Lynn Hue Nguyen; Kong Chen; Jeremy McAleer; Jay K Kolls
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

7.  Vitamin D deficiency in patients with Graves' disease: probably something more than a casual association.

Authors:  Mario Rotondi; Luca Chiovato
Journal:  Endocrine       Date:  2012-08-25       Impact factor: 3.633

8.  A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.

Authors:  Sandra M McLachlan; Holly A Aliesky; Basil Rapoport
Journal:  Thyroid       Date:  2019-07-03       Impact factor: 6.568

Review 9.  Vitamin D and autoimmune thyroid diseases: facts and unresolved questions.

Authors:  Giorgia Bizzaro; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

10.  Attenuation of induced hyperthyroidism in mice by pretreatment with thyrotropin receptor protein: deviation of thyroid-stimulating to nonfunctional antibodies.

Authors:  Alexander V Misharin; Yuji Nagayama; Holly A Aliesky; Yumiko Mizutori; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2009-04-23       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.